4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059634
10% owner bought 325,000 shares at $15.00 ($4,875,000)
- 10% owner acquired 4,319,328 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novartis Bioventures Ltd 10% owner | 2014-09-22 | Conversion | +4,319,328 | 4,319,328 | D: show line 1 in the form | ||
| Novartis Bioventures Ltd 10% owner | 2014-09-22 | Purchase | +325,000 | $15.00 | $4,875,000 | 4,644,328 | D: show line 2 in the form |
| Open-market purchases · 325,000 sh · avg $15.00 · $4,875,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Bioventures Ltd 10% owner | 2014-09-22 | Conversion · Series D-1 Preferred Stock | −15,396,431 | 0 | D: show line 3 in the form | |||||
| Novartis Bioventures Ltd 10% owner | 2014-09-22 | Conversion · Series D-2 Preferred Stock | −1,539,643 | 0 | D: show line 4 in the form | |||||
| Novartis Bioventures Ltd 10% owner | 2014-09-22 | Conversion · Series D-3 Preferred Stock | −13,222,826 | 0 | D: show line 5 in the form | |||||
| Novartis Bioventures Ltd 10% owner | 2014-09-22 | Conversion · Series E Preferred Stock | −15,064,469 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…